Related references
Note: Only part of the references are listed.Good Decision Making Requires Good Communication
Baruch Fischhoff
DRUG SAFETY (2013)
Application of the Benefit-Risk Action Team (BRAT) Framework in Pharmaceutical R&D: Results From a Pilot Program
Rebecca Noel et al.
DRUG INFORMATION JOURNAL (2012)
Application of the BRAT Framework to Case Studies: Observations and Insights
B. S. Levitan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines
P. M. Coplan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Refining the Benefit-Risk Framework for the Assessment of Medicines: Valuing and Weighting Benefit and Risk Parameters
S. Walker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
A Review of Quantitative Risk-Benefit Methodologies for Assessing Drug Safety and Efficacy-Report of the ISPOR Risk-Benefit Management Working Group
Jeff J. Guo et al.
VALUE IN HEALTH (2010)